Presumed influence of Direct-to-Consumer (DTC) prescription drug advertising on patients the physician's perspective

Journal of Advertising

Volumn 36, Issue 3, 2007, Pages 151-172

  Huh, Jisu ^a   Langteau, Rita ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34948909679     PISSN: 00913367     EISSN: None     Source Type: Journal    
DOI: 10.2753/JOA0091-3367360312     Document Type: Article

References (81)

1. Advertising Age (2005), "Fiftieth Annual 100 Leading National Advertisers" (June 27), available at www.adage.com/images/ random/lna2005.pdf (accessed February 10, 2006).
2. Allison-Ottey, Sharon D., Karen Ruffin, and Kimberly B. Allison (2002), "To Do No Harm' Survey of NMA Physicians Regarding Perceptions on DTC Advertisements," National Journal of the Medical Association, 94 (4), 194-202.
3. American Academy of Pediatrics (2003), "Pediatricians' Attitudes Towards and Experiences with Direct-to-Consumer Advertising (DTCA) of Prescription Drugs: A National Survey" (abstract), available at www.aap.org/research/periodicsurvey/ ps52acadhlth03.htm (accessed February 10, 2006).
4. American Medical Association (AMA) (2003), "H-105.988 Direct-to-Consumer Advertising (DTCA) of Prescription Drugs," available at www.ama-assn.org/apps/pf_online?f_ n=browse&doc=policyfiles/HnE/H-105.988. HTM (accessed February 23, 2005).
5. Armstrong, J. Scott, and Terry S. Overton (1977), "Estimating Nonresponse Bias in Mail Surveys," Journal of Marketing Research, 14 (3), 396-402.
6. Arnould, Eric, Linda Price, and George M. Zinkhan (2002), Consumers, New York: McGraw-Hill.
7. Bédard, Jean, and Micheline T. H. Chi (1992), "Expertise, " Current Directions in Psychological Science, 1 (4), 135-139.
8. Borzekowski, Dina L. G., and Albert C. Gunther (2004), "The Presumed Influence Model: Linking Social and Media [Mis]perceptions with Youth Smoking Susceptibility," Journal of Adolescent Health, 34 (2), 153.
9. Brosius, Hans-Bernd, and Dirk Engel (1996), "The Causes of Third-Person Effects: Unrealistic Optimism, Impersonal Impact, or Generalized Negative Attitudes Towards Media Influence?" International Journal of Public Opinion Research, 8 (2), 142-162.
10. Calfee, John E. (2002), "Public Policy Issues in Direct-to-Consumer Advertising of Prescription Drugs," Journal of Public Policy and Marketing, 21 (2), 174-193.
11. Chapin, John R. (1999), "Third-Person Perception and Sexual Risk Taking Among Minority 'At-Risk' Youth," Mass Communication and Society, 2 (3/4), 163-173.
12. Cutrer, Christine M., and Andreas M. Pleil (1991), "Potential Outcomes Associated with Direct-to-Consumer Advertising of Prescription Drugs: Physicians' Perspectives," Journal of Pharmaceutical Marketing and Management, 5 (3), 3-19.
13. Davison, W. Phillips (1983), "The Third-Person Effect in Communication," Public Opinion Quarterly, 47 (1), 1-15.
14. DeLorme, Denise, Jisu Huh, and Leonard N. Reid (2006), "Perceived Effects of DTC Prescription Drug Advertising on Self and Others: A Third-Person Effect Study of Older Consumers," Journal of Advertising, 35 (3), 49-68.
15. Drug Industry Daily (2005), "Industry Warns FDA Not to Prohibit DTC; Agency Considering New Rules" (November 2), LexisNexis Academic database (accessed January 5, 2006).
16. Duck, Julie M., and Barbara-Ann Mullin (1995), "The Perceived Impact of the Mass Media: Reconsidering the Third Person Effect," European Journal of Social Psychology, 25 (1), 77-93.
17. _, Deborah J. Terry, and Michael A. Hogg (1995), "The Perceived Influence of AIDS Advertising: The Third-Person Effect in the Context of Positive Media Content," Basic and Applied Social Psychology, 17 (3), 117-140.
18. Ericsson, K. Anders (2005), "Recent Advances in Expertise Research: A Commentary on the Contributions to the Special Issue," Applied Cognitive Psychology, 19 (2), 233-241.
19. Findlay, Steven D. (2001), "Direct-to-Consumer Promotion of Prescription Drugs: Economic Implications for Patients, Payers and Providers," Pharmacoeconomics, 19 (2), 109-119.
20. Fishbein, Martin (1980), "A Theory of Reasoned Action: Some Applications and Implications," in Nebraska Symposium on Motivation, vol. 27, Herbert E. Howe and Monte M. Page, eds., Lincoln: University of Nebraska Press, 65-116.
21. Gonul, Fusun F., Franklin Carter, and Jerry Wind (2000), "What Kind of Patients and Physicians Value Direct-to-Consumer Advertising of Prescription Drugs," Health Care Management Science, 3 (3), 215-226.
22. Gunther, Albert (1991), "What We Think Others Think," Communication Research, 18 (3), 355-372.
23. _, and J. Douglas Storey (2003), "The Influence of Presumed Influence," Journal of Communication, 53 (2), 199-215.
24. _, and Esther Thorson (1992), "Perceived Persuasive Effects of Product Commercials and Public Service Announcements: Third-Person Effects in New Domains," Communication Research, 19 (5), 574-596.
25. Hair, Joseph F., Rolph E. Anderson, Ronald L. Tatham, and William C. Black (1998), Multivariate Data Analysis, 5th ed., Upper Saddle River, NJ: Prentice Hall.
26. Heider, Fritz (1958), The Psychology of Interpersonal Relations, New York: John Wiley.
27. Hense, Richard, and Christian Wright (1992), "The Development of the Attitudes Toward Censorship Questionnaire, "Journal of Applied Social Psychology, 22 (21), 1666-1675.
28. Hoffner, Cynthia, and Martha Buchanan (2002), "Parents' Responses to Television Violence: The Third-Person Perception, Parental Mediation, and Support for Censorship," Media Psychology, 4 (3), 231-252.
29. Hollon, Matthew F. (1999), "Direct-to-Consumer Marketing of Prescription Drugs: Creating Consumer Demand," Journal of the American Medical Association, 281 (4), 382-384.
30. Huh, Jisu, Denise DeLorme, and Leonard N. Reid (2004), "The Third-Person Effect and Its Influence on Behavioral Outcomes in a Product Advertising Context: The Case of Direct-to-Consumer Prescription Drug Advertising," Communication Research, 31 (5), 568-599.
31. IMS Health (1998), "Majority of Physicians Have Negative View Towards DTC Advertising," press release (September 15).
32. _ (2004), "Total U.S. Promotional Spend by Type, 2003," available at www.imshealth.com/ims/portal/front/ articleC/0,2777, 6599_44304752_44304752_448890,0.html (accessed February 23, 2005).
33. Jensen, Jakob D., and Ryan J. Hurley (2005), "Third-Person Effects and the Environment: Social Distance, Social Desirability, and Presumed Behavior, "Journal of Communication, 55 (2), 242-256.
34. Jones, Edward E., and Keith E. Davis (1965), "From Act to Dispositions: The Attribution Process in Person Perception," in Advances in Experimental Social Psychology, vol. 2, Leonard Berkowitz, ed., New York: Academic Press, 219-266.
35. Kelley, Harold H. (1972), "Attribution in Social Interaction," in Attribution: Perceiving the Causes of Behavior, Edward E. Jones, David E. Kanouse, Harold H. Kelley, Richard E. Nisbett, Stuart Valins, and Bernard Weiner, eds., Morristown, NJ: General Learning Press, 1-26.
36. Kravitz, Richard L., Ronald M. Epstein, Mitchell D. Feldman, Carol E. Franz, Rahman Azari, Michael S. Wilkes, Ladson Hinton, and Peter Franks (2005), "Influence of Patients' Requests for Direct-to-Consumer Advertised Antidepressants: A Randomized Controlled Trial,"JAMA, 293 (16), 1995-2002.
37. Lexchin, Joel, and Barbara Mintzes (2002), "Direct-to-Consumer Advertising of Prescription Drugs: The Evidence Says No," Journal of Public Policy and Marketing, 21 (2), 194-201.
38. Lipsky, Martin S., and Christine A. Taylor (1997), "The Opinionsand Experiences of Family Physicians Regarding Direct-to-Consumer Advertising," Journal of Family Practice, 45 (6), 495-499.
39. MacKenzie, Scott B., and Richard J. Lutz (1989), "An Empirical Examination of the Antecedents of Attitude Toward the Ad in an Advertising Pretesting Context," Journal of Marketing, 53 (2), 48-65.
40. McClosky, Herbert, and Alida Brill (1983), Dimensions of Tolerance: What Americans Believe About Civil Liberties, New York: Russell Sage Foundation.
41. Meirick, Patrick C. (2004), "Topic-Relevant Reference Groups and Dimensions of Distance," Communication Research, 31 (2), 234-255.
42. Mintzes, Barbara (2001), An Assessment of the Health System Impacts of Direct-to-Consumer Advertising of Prescription Medicines (DTCA), vol. 2: Literature Review: Direct-to-Consumer Advertising of Prescription Drugs: What Do We Know Thus Far About Its Effects on Health and Health Care Services? (August), University of British Columbia: UBC Centre for Health Services and Policy Research.
43. _, Morris L. Barer, Richard L. Kravitz, Ken Bassett, Joel Lexchin, Arminée Kazanjian, Robert G. Evans, Richard Pan, and Stephan A. Marion (2003), "How Does Direct-to-Consumer Advertising (DTCA) Affect Prescribing? A Survey in Primary Care Environments With and Without Legal DTCA," Canadian Medical Association Journal, 169 (5), 405-412.
44. Muehling, Darrel D. (1987), "An Investigation of Factors Underlying Attitude-Toward-Advertising-in-General," Journal of Advertising, 16 (1), 32-40.
45. Murray, Elizabeth, Bernard Lo, Lance Pollack, Karen Donelan, and Ken Lee (2003), "Direct-to-Consumer Advertising: Physicians' Views of Its Effects on Quality of Care and the Doctor-Patient Relationship," Journal of the American Board of Family Practice, 16 (6), 513-524.
46. Mutz, Diana C. (1989), "The Influence of Perceptions of Media Influence: Third Person Effects and the Public Expression of Opinions," International Journal of Public Opinion Research, 1 (1), 3-23.
47. Nadal, Caroline L. (2001), "Notes and Comments: The Societal Value of Prescription Drug Advertisements in the New Millennium: Targeted Consumers Become the Learned," Journal of Law and Policy, 451, LexisNexis Academic database (accessed December 2, 2002).
48. National Health Council (2002), "Direct-to-Consumer Prescription Drug Advertising: Overview and Recommendations" (January), available at www.nationalhealthcouncil.org/ advocacy/DTC_paper.pdf (accessed February 10, 2006).
49. Ostrove, Nancy (2001), Statement of Nancy Ostrove, Ph.D., Deputy Director of the Division of Drug Marketing, Advertising and Communications of the Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Department of Health and Human Services, Before the Subcommittee on Consumer Affairs, Foreign Commerce and Tourism, Senate Committee on Commerce, Science, and Transportation (July 24), available at www.fda.gov/ola/2001/ drugprom00724.html (accessed February 23, 2005).
50. Park, Sung-Yeon (2005), "The Influence of Presumed Media Influence on Women's Desire to Be Thin," Communication Research, 32 (5), 594-614.
51. Patel, VimlaL., Robert Glaser, and Jose F. Arocha (2000), "Cognition and Expertise: Acquisition of Medical Competence," Clinical and Investigative Medicine, 23 (4), 256-260.
52. Paul, David P., Amy Handlin, and Angela D'Auria Stanton (2002), "Primary Care Physicians' Attitudes Toward Direct-to-Consumer Advertising of Prescription Drugs: Still Crazy After AU These Years,"Journal of Consumer Marketing, 19 (7), 564-574.
53. Perloff, Richard M. (1989), "Ego-Involvement and the Third Person Effect of Televised News Coverage," Communication Research, 16 (2), 236-262.
54. Petroshius, Susan M., Philip A. Titus, and Kathryn J. Hatch (1995), "Physician Attitudes Toward Pharmaceutical Drug Advertising," Journal of Advertising Research, 35 (6), 41-51.
55. Pines, Wayne L. (1999), "A History and Perspective on Direct-to-Consumer Promotion," Food and Drug Law Journal, 54 (4), 489-518.
56. Pollay, Richard W., and Banwari Mittal (1993), "Here's the Beef: Factors, Determinants, and Segments in Consumer Criticism of Advertising, " Journal of Marketing, 57 (3), 99-114.
57. Prevention and APA (American Pharmaceutical Association) (1999), National Survey of Consumer Reactions to Direct-to-Consumer Advertising (July).
58. _ (2001), Fifth Annual Survey: Consumer Reactions to DTC Advertising of Prescription Medicines, 2001-2002.
59. Reardon, Thomas (1999), "Direct-to-Consumer Advertisements of Prescription Drugs: The Physician Perspective," in IBCs 1999 Inaugural DTC Marketing Congress, Southborough, MA: IBC.
60. Robinson, Andrew R., Kirsten B. Hohmann, Julie I. Rifkin, Daniel Topp, Christine M. Gilroy, Jeffrey A. Pickard, and Robert J. Anderson (2004), "Direct-to-Consumer Pharmaceutical Advertising: Physician and Public Opinion and Potential Effects on the Physician-Patient Relationship," Archives of Internal Medicine, 164 (4), 427-432.
61. Rosenthal, Meredith B., Ernst R. Berndt, Julie M. Donohue, Richard G. Frank, and Arnold M. Epstein (2002), "Promotion of Prescription Drugs to Consumers," New England Journal of Medicine, 346 (7), 498-505.
62. Rucinski, Dianne, and Charles T. Salmon (1990), "The 'Other' as the Vulnerable Voter: A Study of the Third-Person Effect in the 1988 U.S. Presidential Campaign," International Journal of Public Opinion Research, 2 (4), 345-368.
63. Salwen, Michael B. (1998), "Perception of Media Influence and Support for Censorship," Communication Research, 25 (3), 259-285.
64. _, and Michel Dupagne (1999), "The Third-Person Effect," Communication Research, 26 (5), 523-549.
65. Stavchansky, Liza E. (2000), "An Exploratory Study of Consumer, Community Pharmacist, and Physician Attitudes and Comprehension of Direct-to-Consumer Prescription Drug Advertising," unpublished doctoral dissertation, University of Texas at Austin.
66. Sternthal, Brian, and C. Samuel Craig (1982), Consumer Behavior: An Information Processing Perspective, Englewood Cliffs, NJ: Prentice Hall.
67. Thomaselli, Rich (2005), "Don't Count Out DTC Marketers," Advertising Age (June 27), S-16.
68. Tsfati, Yariv, and Jonathan Cohen (2005), "The Influence of Presumed Media Influence on Democratic Legitimacy: The Case of Gaza Settlers," Communication Research, 32 (6), 794-821.
69. U.S. Food and Drug Administration (FDA) (2004a), "Patient and Physician Attitudes and Behaviors Associated with DTC Promotion of Prescription Drugs: Summary of FDA Survey Research Results," Final Report (November 19), available at www.fda.gov/cdr/ddmac/Final%20Report/FRfinal1111904.pdf (accessed February 10, 2006).
70. _ (2004b), "FDA News: New FDA Draft Guidances Aim to Improve Health Information," press release (February 4), available at www.fda.gov/bbs/ topics/news/2004/new01016.html (accessed February 23, 2005).
71. _ (2004c), "Guidance for Industry Brief Summary: Disclosing Risk Information in Consumer-Directed Print Advertisements [Draft Guidance]," available at www.fda.gov/ cder/guidance/5669dft.pdf (accessed February 23, 2005).
72. _, Center for Drug Evaluation and Research (CDER) (1999), Attitudes and Behaviors Associated with Direct-to-Consumer Promotion of Prescription Drugs, available at www.fda.gov/cder/ddmac/research.htm (accessed February 23, 2005).
73. Vecchio, Anthony (1997), "Direct Concerns: Pharmacists Wary of Surge in Consumer Rx Drug Ads," Drug Topics (July 21), available at www.drugtopics.com (accessed February 23, 2005).
74. Viale, Pamela H., and Deanna S. Yamamoto (2004), "The Attitudes and Beliefs of Oncology Nurse Practitioners Regarding Direct-to-Consumer Advertising of Prescription Medications," Oncology Nursing Forum, 31 (4), 777-784.
75. Weissman, Joel S., David Blumenthal, Alvin J. Silk, Michael Newman, Kinga Zapert, Robert Leitman, and Sandra Felbelmann (2004), "Physicians Report on Patient Encounters Involving Direct-to-Consumer Advertising," Health Affairs, 23 (3), W4219-4233.
76. Wilkes, Michael S., Robert A. Bell, and Richard L. Kravitz (2000), "Direct-to-Consumer Prescription Drug Advertising: Trends, Impact, and Implications," Health Affairs, 19 (2), 110-128.
77. Woodcock, Janet (2001), Statement of Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Department of Health and Human Services, Before the Subcommittee on Health, House Committee on Energy and Commerce, for the Hearing on "Recent Developments Which May Impact Consumer Access to, and Demand for, Pharmaceuticals" (June 13), available at www.fda.gov/ola/2001/ cderwork0613.html (accessed February 23, 2005).
78. _ (2003), Statement of Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Department of Health and Human Services, Before the Senate Special Committeeon Aging (July 22), available at www.fda.gov/ola/2003/ AdvertisingofPrescriptionDrugs0722.html (accessed February 23, 2005).
79. Youn, Seounmi, Ronald J. Faber, and Dhavan V Shah (2000), "Restricting Gambling Advertising and the Third-Person Effect," Psychology and Marketing, 17 (7), 633-649.
80. Yuan, Yilian, and Nancy Duckwitz (2002), "Doctors and DTC," Pharmaceutical Executive (August), 1-7.
81. Zachry, Woodie M., James E. Dalen, and Terrence R. Jackson (2003), "Clinicians Responses to Direct-to-Consumer Advertising of Prescription Medications," Archives of Internal Medicine, 163 (15), 1808-1812.